We only have this paper's title and publication details.
Read it at the sourceAnalysis reveals NIH programs and leadership face significant scrutiny, while other agencies are less affected.
NIH programs and leadership are hit hard; other science agencies are barely mentioned
No takes yet. Share an insight, caveat, or question.
Jeffrey Mervis (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: